JP2024507221A5 - - Google Patents

Info

Publication number
JP2024507221A5
JP2024507221A5 JP2023550043A JP2023550043A JP2024507221A5 JP 2024507221 A5 JP2024507221 A5 JP 2024507221A5 JP 2023550043 A JP2023550043 A JP 2023550043A JP 2023550043 A JP2023550043 A JP 2023550043A JP 2024507221 A5 JP2024507221 A5 JP 2024507221A5
Authority
JP
Japan
Application number
JP2023550043A
Other languages
Japanese (ja)
Other versions
JPWO2022178244A5 (https=
JP2024507221A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/016962 external-priority patent/WO2022178244A1/en
Publication of JP2024507221A publication Critical patent/JP2024507221A/ja
Publication of JP2024507221A5 publication Critical patent/JP2024507221A5/ja
Publication of JPWO2022178244A5 publication Critical patent/JPWO2022178244A5/ja
Pending legal-status Critical Current

Links

JP2023550043A 2021-02-19 2022-02-18 Ｒａｆ阻害剤とｍｅｋ阻害剤の組合せ Pending JP2024507221A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163151425P 2021-02-19 2021-02-19
US63/151,425 2021-02-19
US202163173158P 2021-04-09 2021-04-09
US63/173,158 2021-04-09
PCT/US2022/016962 WO2022178244A1 (en) 2021-02-19 2022-02-18 Combination of raf inhibitor and mek inhibitor

Publications (3)

Publication Number Publication Date
JP2024507221A JP2024507221A (ja) 2024-02-16
JP2024507221A5 true JP2024507221A5 (https=) 2025-02-27
JPWO2022178244A5 JPWO2022178244A5 (https=) 2025-02-27

Family

ID=82931723

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023550043A Pending JP2024507221A (ja) 2021-02-19 2022-02-18 Ｒａｆ阻害剤とｍｅｋ阻害剤の組合せ

Country Status (10)

Country Link
US (1) US20240058338A1 (https=)
EP (1) EP4294400A4 (https=)
JP (1) JP2024507221A (https=)
KR (1) KR20230147136A (https=)
AU (1) AU2022223437A1 (https=)
CA (1) CA3211167A1 (https=)
IL (1) IL305250A (https=)
MX (1) MX2023009642A (https=)
WO (1) WO2022178244A1 (https=)
ZA (1) ZA202307921B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4408430A4 (en) * 2021-10-01 2025-07-30 Day One Biopharmaceuticals Inc RAF KINASE INHIBITORS FOR THE TREATMENT OF TUMORS WITH GENE FUSIONS
WO2025106686A1 (en) * 2023-11-15 2025-05-22 Day One Biopharmaceuticals, Inc. Methods of treating pediatric low-grade glioma

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104428001A (zh) * 2012-03-30 2015-03-18 武田药品工业有限公司 Raf抑制剂和mek抑制剂在黑素瘤治疗中的投与
CA3240745A1 (en) * 2013-12-20 2015-06-25 Biomed Valley Discoveries, Inc. Cancer treatment using combinations of erk and raf inhibitors
UY36046A (es) * 2014-03-26 2015-10-30 Millennium Pharm Inc Formulaciones farmacéuticas, procesos para la preparación y métodos de uso
WO2016025648A1 (en) * 2014-08-13 2016-02-18 Celgene Avilomics Research, Inc. Combinations of an erk inhibitor and a raf inhibitor and related methods
AU2018329925B2 (en) * 2017-09-08 2025-05-29 F. Hoffmann-La Roche Ag Diagnostic and therapeutic methods for cancer

Similar Documents

Publication Publication Date Title
JP2024507221A5 (https=)
CL2025004149A1 (es) Método y sistema para la recuperación de elementos valiosos a partir de la materia prima derivada de los relaves de minas de cobre.
CL2025003429A1 (es) Correa para máquina de pulpa o papel con sensores para detectar la presión durante el funcionamiento.
BR102023014872A2 (https=)
BR102023007252A2 (https=)
BR202022009269U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
CN307045978S (https=)
CN307045185S (https=)
BY13149U (https=)
CN307049652S (https=)
CN307049329S (https=)
CN307048469S (https=)
CN307048257S (https=)
CN307047377S (https=)
BY13145U (https=)
CN307047237S (https=)
BY13144U (https=)
CN307046985S (https=)
CN307046679S (https=)
CN307046660S (https=)
CN307046526S (https=)
CN307046462S (https=)
BY13151U (https=)